Cargando…

Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic Cancer: A Retrospective Cohort Study

Background: Epidemiologic studies have produced conflicting results on the effects of metformin on pancreatic cancer. This study aimed to observe and analyze whether metformin use is associated with better prognosis in pancreatic cancer. Materials and Methods: In this retrospective cohort study, all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yang, Qian, Fang-jing, Ye, Zhi-qiang, Xie, Wen-xia, He, You-di, Huang, Jing-ren, Tian, Ling, Gu, Dian-na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806383/ https://www.ncbi.nlm.nih.gov/pubmed/36583563 http://dx.doi.org/10.1177/15330338221138208

Ejemplares similares

MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancreatic cancer cells
por: Ye, Zhi-Qiang, et al.
Publicado: (2021)

Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner
por: Xia, Wenjiao, et al.
Publicado: (2021)

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017)

MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer
por: Ye, Zhi-qiang, et al.
Publicado: (2020)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014)

Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells
por: Lu, Ran, et al.
Publicado: (2018)

Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo
por: Chen, Ya-Hui, et al.
Publicado: (2021)

Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
por: Gou, Shanmiao, et al.
Publicado: (2013)

Metformin and Its Benefits for Various Diseases
por: Lv, Ziquan, et al.
Publicado: (2020)

Anticancer activity of metformin: a systematic review of the literature
por: Aljofan, Mohamad, et al.
Publicado: (2019)

The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
por: Yamanashi, Takehiko, et al.
Publicado: (2022)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Metformin induced acute pancreatitis
por: Alsubaie, Sadeem, et al.
Publicado: (2013)

The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug
por: Sacco, Francesca, et al.
Publicado: (2016)

Novel application of metformin combined with targeted drugs on anticancer treatment
por: Deng, Jun, et al.
Publicado: (2018)

Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Understanding the benefit of metformin use in cancer treatment
por: Dowling, Ryan JO, et al.
Publicado: (2011)

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020)

Anticancer Effects of Baicalein in Pancreatic Neuroendocrine Tumors In Vitro and In Vivo
por: Tian, Ye, et al.
Publicado: (2017)

microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
por: Fang, Chi, et al.
Publicado: (2018)

Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
por: Fang, Chi, et al.
Publicado: (2021)

Diabetes, pancreatic cancer, and metformin therapy
por: Gong, Jun, et al.
Publicado: (2014)

Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020)

Mechanisms and effects of metformin on skeletal muscle disorders
por: Shang, Ren, et al.
Publicado: (2023)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663
por: Gu, Yuqing, et al.
Publicado: (2020)

PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
por: Zhao, Yi, et al.
Publicado: (2016)

Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial
por: Rizvi, Fatima, et al.
Publicado: (2021)

Novel Metformin Analogues for Treatment of Pancreatic Cancer
por: Burton, Lorena P, et al.
Publicado: (2021)

Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study
por: Riera-Borrull, Marta, et al.
Publicado: (2017)

Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
por: Giaccari, Andrea, et al.
Publicado: (2021)

Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells
por: Warkad, Madhuri Shende, et al.
Publicado: (2021)

Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis
por: You, Ganhua, et al.
Publicado: (2020)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer
por: Jiang, Ming-jie, et al.
Publicado: (2020)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages
por: Li, Zhuofei, et al.
Publicado: (2022)

Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells
por: Sharma, Ankit, et al.
Publicado: (2019)

Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin
por: Abdelrahman, Sherin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_444s0ag7i96k60mko1vhh7rcln